Plasmapp exports 9.7 billion plasma sterilizers to Iran

Medical device startup Plasmapp (CEO Lim You-bong) exports plasma sterilizers to large Iranian hospitals.

Plasmapp announced on the 17th that it has recently signed a 9.7 billion won contract with U.S. trader Modava Persian to export ultra-high-temperature plasma sterilizers and management systems, and will supply 1,500 units over the next two years.

<Lim You-bong, CEO of Plasmapp (left), is showing a contract with Masod Sarahi, CEO of Modava Persian, after signing a contract to export plasma sterilizers.>

All plasma sterilizers supplied to Modaba Persian in the U.S. will be installed in "Day Hospital," a large Iranian hospital.

The ultra-high-speed low-temperature plasma sterilizer developed by Plasmapp can quickly sterilize at low temperatures after generating plasma in a packaging pouch. When a medical device to be disinfected is put in a packaging pouch coated with a special electrode material, sealed, and put into a PC-like power supply (STERLINK), plasma is quickly formed inside the pouch, sterilizing the medical device within five minutes, vacuum packaging, and aseptic preservation.

<Lim You-bong, CEO of Plasma Map (left), and Lee Yong-kwan, CEO of Blue Point Partners, are introducing low-temperature plasma sterilizers.>

Another advantage is that the sterilization process time is more than 10 times faster than the existing large plasma sterilization equipment. The price is also one-tenth that of the existing large plasma equipment that costs tens of millions of won.

Plasmapp also provided a service platform "ITS (Instrument Tracking Systems)" to guarantee sterilization reliability, enabling real-time management and remote response.

Plasmapp expects the contract to allow additional exports to the Middle East.

CEO Lim You-bong said, "Even though it is in the early stages of the business, we have already received a lot of interest and love calls from overseas markets. With this contract, we plan to continue to strengthen our product competitiveness and target global markets."